Sign Out
Pregnancy: There is limited experience with use of Nimenrix in pregnant women.
Animal studies with Nimenrix do not indicate direct or indirect harmful effects with respect to fertility, pregnancy, embryo/foetal development, parturition or post-natal development (see Pharmacology: Toxicology: Preclinical Safety Data under Actions).
Nimenrix should be used during pregnancy only when clearly needed, and the possible advantages outweigh the potential risks for the foetus.
Lactation: The safety of Nimenrix when administered to breast-feeding women has not been evaluated. It is unknown whether Nimenrix is excreted in human breast milk.
Nimenrix should only be used during breast-feeding when the possible advantages outweigh the potential risks.
